Maharashtra has reported the highest daily new cases at 9,855. This is the highest number recorded in the state since October 18 when 10,259 new cases were reported

IT major Infosys on Wednesday said it will cover the vaccination cost for its employees in India and their family members; Bharat Biotech has announced the Phase 3 clinical trial results for its coronavirus vaccine candidate Covaxin; The COVAX initiative, co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi) and the World Health Organization (WHO), will supply 237 million doses of the AstraZeneca-Oxford COVID-19 vaccine to 142 countries by May-end. Watch this and more on News Blast.Also Read: Canada receives first shipment of 5 lakh COVID-19 vaccine doses from Serum Institute

Bharat Biotech published the interim efficacy report of phase 3 clinical trial on its COVID-19 vaccine, officially known as Covaxin. The indigenous COVID-19 vaccine is found to be 81 per cent effective in preventing the virus

Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81% effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said

Digital media norms to be administered by Centre, not states The Information and Broadcasting (I&B) Ministry on Wednesday issued memorandum to states and union territories saying that the new rules for digital news publishers and over-the-top (OTT) platforms are to be administered by the Centre, not the states. The government had notified the Information Technology (Intermediary Guidelines and Digital Media Ethics Codes) Rules, 2021 on February 25. Defence equipment sales to India sho...

Very early this morning, our first half a million doses of the AstraZeneca-Oxford vaccine from the Serum Institute arrived in Canada, said Prime Minister Justin Trudeau

So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy

Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report

Meanwhile, consulting and processing services provider Accenture also said that it will cover the cost for employees and dependents eligible for vaccination.

The interim efficacy trend of 81 per cent, analysed as per the protocol approved by the Drugs Controller General of India, puts it at par with other global front-runner vaccines, stated ICMR

Data from 25,800 participants who received a vaccine or placebo in 1:1 ratio showed that the vaccine was well-tolerated; Bharat Biotech said the trial conducted with ICMR was the largest in India

Over 110 million doses of this to about 60 countries will be met through the AstraZeneca (AZ)-Serum Institute of India partnership

India's fuel demand to rise 9.8% in year to March 2022 India's fuel consumption could rise by 9.8% in the year to March 2022, its highest pace of growth in six years, driven by robust demand for gasoline and gasoil in Asia's third largest economy, according to initial government projections. Higher expectation of fuel consumption, a proxy for oil demand, points to a sharp recovery in industrial activity in the economy hit hard by the pandemic. Economic recovery lost steam in Jan-Feb: Axis...

Some said that the blue-coloured tape, situated above the company's signature smiling \"arrow\" logo, had an uncanny resemblance to the infamous toothbrush moustache worn by Nazi dictator Adolf Hitler

\"The UK has ordered 100 million doses of AstraZeneca's COVID-19 vaccine, of which 10 million doses will come from the Serum Institute of India,\" a UK government spokesperson told Reuters

The researchers, including those from Public Health England (PHE), compared the rate of hospitalisation and deaths in confirmed COVID-19 patients aged over 80 who were vaccinated more than 14 days before testing positive, with unvaccinated cases

Some 500,000 doses made by SII, the world's largest vaccine producer, are set to arrive in Canada on Wednesday, a surprise boost for Canada's lagging vaccination drive

More than 1.07 crore (1,07,86,457) people have recovered so far with 11,288 patients having recuperated in a span of 24 hours

Once approved, the product can be marketed in the 27 European Union (EU) member countries and European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein

The real-world study involved around 1.2 million people in Israel. Pfizer vaccine has also proved to be effective against B.1.1.7 variant, also known as the UK variant of coronavirus